21182 results for "fc 26 coins Buyfc26coins.com is EA Sports official for FC 26 coins The service is affordable and quick..6Xgd"

in 25.62 milliseconds.

• scRNA primaries

  Single cell RNA-seq for primary samples

  Dataset EGAD00001006135

• scWGS chordblood

  Single cell WGS (low pass) for chord blood samples

  Dataset EGAD00001006136

• scWGS PDX

  Single cell WGS (low pass) for PT1-derived PDX samples

  Dataset EGAD00001006137

• scWGS primaries

  Single cell WGS (low pass) for primary samples

  Dataset EGAD00001006138

• Orolova hIPSC data access policy

  DAC associated with the hiPSC cell lines generated by the Orlova lab.

  Dac EGAC50000000744

• Hepatocellular carcinoma xenografts established from needle biopsies preserve the characteristics of the originating tumors

  Study EGAS00001003396

• Dataset for colorectal_cancer-RNA

  Rare cancer sequencing data of 97 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired

  Dataset EGAD00001008855

• Dataset for head_and_neck_cancer-RNA

  Rare cancer sequencing data of 92 runs in tumor/control pairs, which were uploaded to umbrella studies. The sequencing was always paired

  Dataset EGAD00001008861

• Solve-RD_EuroNMD_cohort-1_DF1+2_V1

  Solve-RD data submitted to the ERN-EuroNMD cohort for re-analysis (Data freeze 1+2) v1

  Dataset EGAD00001009768

• Genomic and Epigenomic Features of Primary and Recurrent Hepatocellular Carcinomas

  Intratumor heterogeneity and divergent clonal lineages within and among primary and recurrent hepatocellular carcinomas (HCCs) produce challenges to patient management. We investigated genetic and epigenetic variations within liver tumors, among hepatic lesions, and between primary and relapsing tumors. We performed whole-genome, whole-exome, or targeted capture sequencing analyses HCC specimens collected from multiple tumor regions and matched initial and recurrent tumors to obtain a systematic evaluation of intra- and intertumor genetic heterogeneity in HCC samples and to identify genetic changes associated with tumor progression and recurrence.

  Study EGAS00001002094